4.7 Article

The max-intracerebral hemorrhage score predicts long-term outcome of intracerebral hemorrhage

Journal

CNS NEUROSCIENCE & THERAPEUTICS
Volume 24, Issue 12, Pages 1149-1155

Publisher

WILEY
DOI: 10.1111/cns.12846

Keywords

external validation; intracerebral hemorrhage; max-intracerebral hemorrhage score; prognosis

Funding

  1. National Key Technology Research and Development Program of the Ministry of Science and Technology of The People's Republic of China [2015BAI12B02]
  2. Beijing Municipal Science & Technology Commission [D151100002015003]
  3. Beijing Municipal Administration of Hospitals' Mission Plan [SML20150502]

Ask authors/readers for more resources

Aims Little is known about the performance of the maximally treated intracerebral hemorrhage (max-ICH) score in predicting unfavorable long-term functional outcome and death in patients with intracerebral hemorrhage (ICH) in China. We aimed to validate the performance of the max-ICH score and compared it with other recognized scores. Methods Results We derived data from the China National Stroke Registry (CNSR). Receiver-operating characteristic (ROC) analysis and Hosmer-Lemeshow test were used to measure the score performance. We compared the performance of max-ICH score with six recognized models, including the ICH score, ICH functional outcome score (ICH-FOS), Essen-ICH score, modified intracerebral hemorrhage (MICH) score, intracerebral hemorrhage grading scale (ICH-GS), and functional outcome (FUNC) score. A total of 2581 patients with spontaneous ICH were enrolled in the study. The max-ICH score was similar or superior to the six existing scores in predicting long-term unfavorable functional outcome after ICH with good discrimination (AUC 0.83, 95% confidence interval [CI] 0.81-0.84) and calibration (Hosmer-Lemeshow P = 0.19). For predicting death, the AUC of max-ICH was 0.81 (95% CI 0.79-0.83). Conclusions The easy-to-use max-ICH score is a reliable tool to predict unfavorable long-term (12-month) functional outcome and death after intracerebral hemorrhage in the Chinese population.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial

Xiaochuan Huo, Gaoting Ma, Xuelei Zhang, Yuesong Pan, Xu Tong, Dapeng Sun, Liping Liu, Yilong Wang, David S. Liebeskind, Yongjun Wang, Vitor Mendes Pereira, Zeguang Ren, Zhongrong Miao

Summary: This article presents the design of a clinical trial investigating the effect of endovascular therapy on neurological functional outcomes in patients with large infarct core.

STROKE AND VASCULAR NEUROLOGY (2023)

Article Clinical Neurology

Prognostic significance of atrial cardiopathy in patients with acute ischemic stroke

Yueyang Wu, Xiaomeng Yang, Jing Jing, Xia Meng, Zixiao Li, Yuesong Pan, Yong Jiang, Hongyi Yan, Xinying Huang, Liping Liu, Xingquan Zhao, Yilong Wang, Hao Li, Yongjun Wang

Summary: This study found that atrial cardiopathy markers, especially PTFV1 and aIAB, are significantly associated with a higher risk of poor prognosis in patients with ischemic stroke.

EUROPEAN STROKE JOURNAL (2023)

Article Clinical Neurology

Genotype-Guided Dual Antiplatelet Use for Transient Ischemic Attack and Minor Stroke by Imaging Status: Subgroup Analysis of the CHANCE-2 Trial

Jing Jing, Xuewei Xie, S. Claiborne Johnston, Philip M. Bath, Zixiao Li, Xingquan Zhao, Liping Liu, Yilong Wang, Qin Xu, Anxin Wang, Yong Jiang, Hao Li, Xia Meng, Yongjun Wang

Summary: This study investigates whether ticagrelor/aspirin can further reduce the risk of stroke recurrence in patients with positive diffusion-weighted imaging (DWI) compared to clopidogrel/aspirin. The results show that ticagrelor/aspirin is associated with a lower risk of stroke in patients with positive DWI compared to clopidogrel/aspirin. Therefore, imaging evaluation should be emphasized in future clinical research and practice to target the best candidates for genotype-guided dual antiplatelet therapy.

ANNALS OF NEUROLOGY (2023)

Article Clinical Neurology

Aminotransferase Level and the Effects of Dual Antiplatelet in Minor Stroke or Transient Ischemic Attack: A post hoc Analysis of a Randomized Control Trial

Yue Suo, Yuesong Pan, Weiqi Chen, Jing Jing, Hongyi Yan, Hao Li, Liping Liu, Xingquan Zhao, Yilong Wang, Xia Meng, Yongjun Wang

Summary: This study aimed to evaluate the impact of aminotransferase levels on the safety and efficacy of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack. The results showed that mild elevation of aminotransferase levels did not undermine the protective efficacy of dual antiplatelet treatment in reducing recurrent stroke or TIA, indicating its safety and effectiveness in these patients.

CEREBROVASCULAR DISEASES (2023)

Article Endocrinology & Metabolism

Increased Resting-State Functional Connectivity as a Compensatory Mechanism for Reduced Brain Volume in Prediabetes and Type 2 Diabetes

Jing Jing, Chang Liu, Wanlin Zhu, Yuesong Pan, Jiyang Jiang, Xueli Cai, Zhe Zhang, Zixiao Li, Yijun Zhou, Xia Meng, Jian Cheng, Yilong Wang, Hao Li, Yong Jiang, Huaguang Zheng, Suying Wang, Haijun Niu, Wei Wen, Perminder S. Sachdev, Tiemin Wei, Tao Liu, Yongjun Wang

Summary: This study investigated the impact of brain structure and function on cognitive function in individuals with diabetes, especially type 2 diabetes. The results showed that compared to individuals with normal glucose metabolism, those with type 2 diabetes had smaller brain volume in various regions and stronger functional connectivity between the bilateral thalamus and brain networks. Additionally, individuals with prediabetes had smaller brain volume in specific regions and stronger functional connectivity between the right thalamus and visual network. Cognitive function was associated with larger thalamus volume and lower functional connectivity with the visual network.

DIABETES CARE (2023)

Article Clinical Neurology

Ten-year trends in sex differences in cardiovascular risk factors, in-hospital management, and outcomes of ischemic stroke in China: Analyses of a nationwide serial cross-sectional survey from 2005 to 2015

Hong-Qiu Gu, Chun-Juan Wang, Xin-Miao Zhang, Yong Jiang, Hao Li, Xia Meng, Xin Yang, Li-Ping Liu, Xing-Quan Zhao, Yi-Long Wang, Yong-Jun Wang, Zi-Xiao Li

Summary: This study conducted a nationwide survey in China from 2005 to 2015, aiming to assess the 10-year trends in sex differences in cardiovascular risk factors, in-hospital management, and outcomes among ischemic stroke patients. The results showed that women with ischemic stroke had different risk factors and treatment outcomes compared to men.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Clinical Neurology

Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trial

Yongjun Wang, Jiejie Li, S. Claiborne Johnston, Graeme J. Hankey, J. Donald Easton, Xia Meng, Fu-Dong Shi, Yilong Wang, Xingquan Zhao, Zixiao Li, Liping Liu, Hongqiu Gu, Yong Jiang, Anxin Wang, Yuesong Pan, Jing Jing, Siying Niu, Hao Li

Summary: The CHANCE-3 study is a randomized, double-blind, placebo-controlled multicenter trial that aims to investigate the efficacy of colchicine therapy in patients with acute minor-to-moderate ischemic stroke or transient ischemic attack. The study will randomly assign 8,238 patients with high-sensitivity CRP level of >= 2 mg/L to receive colchicine or placebo, in addition to optimal medical therapy. The primary outcome is the occurrence of any stroke within 3 months of randomization, with a goal of detecting a 25% reduction in the colchicine group.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Endocrinology & Metabolism

Thyroid Function in Causal Relation to MRI Markers of Cerebral Small Vessel Disease: A Mendelian Randomization Analysis

Yu Tian, Dongxiao Yao, Aoming Jin, Mengxing Wang, Yuesong Pan, Yongjun Wang, Yilong Wang

Summary: This study used 2-sample Mendelian randomization analysis to investigate the causal relationship between thyroid function and the risk of cerebral small vessel disease (CSVD). The results showed that genetically predicted increase in thyrotropin (TSH) was associated with increased white matter microstructural injury, while genetically predicted increase in free thyroxine (FT4) was associated with increased white matter integrity. There were no significant causal relationships of hypothyroidism or hyperthyroidism with CSVD.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Neuroimaging

Cost-effectiveness of endovascular therapy for acute ischemic stroke with large infarct in China

Yuesong Pan, Xiaochuan Huo, Aoming Jin, Thanh N. Nguyen, Gaoting Ma, Xu Tong, Xuelei Zhang, Feng Gao, Ning Ma, Dapeng Mo, Zeguang Ren, Yongjun Wang, Zhongrong Miao

Summary: Endovascular therapy for acute ischemic stroke with large infarction may be cost-effective in China. The study evaluated the cost-effectiveness of endovascular therapy for this condition and found that it was cost-effective compared to medical management alone, starting from the fourth year and throughout the lifetime.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2023)

Article Clinical Neurology

Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial

Yuesong Pan, Xia Meng, Baoshi Yuan, S. Claiborne Johnston, Hao Li, Philip M. Bath, Qiang Dong, Anding Xu, Jing Jing, Jinxi Lin, Yong Jiang, Xuewei Xie, Aoming Jin, Yue Suo, Hongqin Yang, Yefang Feng, Yanhua Zhou, Qing Liu, Xueli Li, Bin Liu, Hui Zhu, Jinguo Zhao, Xuerong Huang, Haitao Li, Yunyun Xiong, Zixiao Li, Yilong Wang, Xingquan Zhao, Liping Liu, Yongjun Wang

Summary: This study compared indobufen with aspirin in reducing the risk of recurrent stroke in patients with moderate-to-severe ischemic stroke. The results showed that indobufen was not non-inferior to aspirin in reducing the risk of recurrent stroke at 90 days. Additionally, there was no significant difference in the risk of moderate or severe bleeding between the two drugs. Therefore, the findings do not support the use of indobufen for secondary stroke prevention in patients with moderate-to-severe ischemic stroke.

LANCET NEUROLOGY (2023)

Article Clinical Neurology

In patients who had a stroke or TIA, enlarged perivascular spaces in basal ganglia may cause future haemorrhagic strokes

Yu Tian, Mengxing Wang, Yuesong Pan, Xia Meng, Xingquan Zhao, Liping Liu, Yongjun Wang, Yilong Wang

Summary: This study examined whether enlarged perivascular spaces (EPVS) can predict adverse clinical outcomes in patients with acute ischaemic stroke (AIS) or transient ischaemic attack (TIA). The results showed that BG-EPVS was associated with a decreased risk of recurrent ischaemic stroke but an increased risk of haemorrhagic stroke, while CSO-EPVS was associated with a decreased risk of disability and all-cause death. Both BG-EPVS and CSO-EPVS were also associated with a decreased risk of subsequent ischaemic stroke in patients with small arterial occlusion (SAO). These findings suggest that EPVS may have important clinical implications in the diagnosis and treatment of stroke patients.

STROKE AND VASCULAR NEUROLOGY (2023)

Article Clinical Neurology

Efficacy and safety of early anticoagulation after endovascular treatment in patients with atrial fibrillation

Yaning Xu, Chengchun Liu, Wei Li, Ximing Nie, Shuhan Huang, Xiaoshu Li, Ya Wu, Wang-Sheng Jin, Jiaojin Jiang, Jun Dong, Yi Yang, Zhiqiang Sun, Wenjun Han, Yanjiang Wang, Liping Liu, Meng Zhang

Summary: This study aimed to evaluate the effect of early anticoagulation after successful recanalisation in acute ischaemic stroke (AIS) patients with atrial fibrillation. The results showed that early anticoagulation can improve functional outcomes without increasing the risk of intracranial haemorrhages.

STROKE AND VASCULAR NEUROLOGY (2023)

Editorial Material Clinical Neurology

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy

David Wang, Christopher Leo, Liping Liu, Li Huang, Lisa Huang, Yun Lu

STROKE AND VASCULAR NEUROLOGY (2023)

Article Clinical Neurology

Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis (BASIS): protocol of a prospective, multicentre, randomised, controlled trial

Xuan Sun, Ming Yang, Dapeng Sun, Guangge Peng, Yiming Deng, Xingquan Zhao, Liping Liu, Ning Ma, Feng Gao, Dapeng Mo, Wengui Yu, Yongjun Wang, Yilong Wang, Zhongrong Miao

Summary: This study is a randomised controlled trial comparing the efficacy and safety of balloon angioplasty plus aggressive medical management (AMM) to AMM alone for symptomatic intracranial artery stenosis (sICAS). The study design is a multicentre, prospective, open-label, blinded end-point trial named BASIS, aiming to investigate whether balloon angioplasty plus AMM can improve clinical outcome compared with AMM alone in sICAS patients.

STROKE AND VASCULAR NEUROLOGY (2023)

Article Clinical Neurology

Tirofiban combined with Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction (STRATEGY): protocol for a multicentre, randomised controlled trial

Xiaoling Liao, Shuo Feng, Yicong Wang, Yuesong Pan, Weiqi Chen, Hui Qu, Xingquan Zhao, Liping Liu, Yongjun Wang, Yilong Wang

Summary: The ongoing STRATEGY trial in China aims to compare the effectiveness and safety of tirofiban combined with aspirin versus placebo combined with aspirin in reducing the risk of recurrence and early neurological deterioration in patients with perforating artery territorial infarction caused by branch atheromatous disease.

STROKE AND VASCULAR NEUROLOGY (2023)

No Data Available